IFI-ED ustekinumab in patients with ulcerative colitis long term on extended follow up

Not Applicable

Recruiting

• Conditions: ulcerative colitis; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12622001332718
• Lead Sponsor: Concord Repatriation General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-17
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients who participated in the UNIFI study (NCT02407236 , DOI: 10.1056/NEJMoa1900750) from Australian sites, and who persisted on ustekimumab therapy as maintenance treatment for their ulcerative colitis

Exclusion Criteria

Patients with no relevant data

Study & Design

• Study Type: Observational
• Study Design: Not specified